598 related articles for article (PubMed ID: 18502017)
41. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
42. Effects of co-administration of dietary sodium arsenate and 2,3-dimercaptopropane-1-sulfonic acid (DMPS) on the rat bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Chen B; Lu X; Le XC; Cohen SM
Toxicology; 2012 Sep; 299(2-3):155-9. PubMed ID: 22664484
[TBL] [Abstract][Full Text] [Related]
43. Microbial metabolite of dimethylarsinic acid is highly toxic and genotoxic.
Kuroda K; Yoshida K; Yoshimura M; Endo Y; Wanibuchi H; Fukushima S; Endo G
Toxicol Appl Pharmacol; 2004 Aug; 198(3):345-53. PubMed ID: 15276414
[TBL] [Abstract][Full Text] [Related]
44. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells.
Sens DA; Park S; Gurel V; Sens MA; Garrett SH; Somji S
Toxicol Sci; 2004 May; 79(1):56-63. PubMed ID: 14976345
[TBL] [Abstract][Full Text] [Related]
45. Trivalent arsenicals are bound to proteins during reductive methylation.
Naranmandura H; Suzuki N; Suzuki KT
Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239
[TBL] [Abstract][Full Text] [Related]
46. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
[TBL] [Abstract][Full Text] [Related]
47. Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats.
Krüger K; Straub H; Hirner AV; Hippler J; Binding N; Musshoff U
Toxicol Appl Pharmacol; 2009 Apr; 236(1):115-23. PubMed ID: 19371632
[TBL] [Abstract][Full Text] [Related]
48. HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota.
Alava P; Tack F; Laing GD; de Wiele TV
Biomed Chromatogr; 2012 Apr; 26(4):524-33. PubMed ID: 21905058
[TBL] [Abstract][Full Text] [Related]
49. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
50. Inorganic arsenic compounds and methylated metabolites induce morphological transformation in two-stage BALB/c 3T3 cell assay and inhibit metabolic cooperation in V79 cell assay.
Tsuchiya T; Tanaka-Kagawa T; Jinno H; Tokunaga H; Sakimoto K; Ando M; Umeda M
Toxicol Sci; 2005 Apr; 84(2):344-51. PubMed ID: 15647599
[TBL] [Abstract][Full Text] [Related]
51. Interaction of trivalent arsenicals with metallothionein.
Jiang G; Gong Z; Li XF; Cullen WR; Le XC
Chem Res Toxicol; 2003 Jul; 16(7):873-80. PubMed ID: 12870890
[TBL] [Abstract][Full Text] [Related]
52. Arsenic species that cause release of iron from ferritin and generation of activated oxygen.
Ahmad S; Kitchin KT; Cullen WR
Arch Biochem Biophys; 2000 Oct; 382(2):195-202. PubMed ID: 11068869
[TBL] [Abstract][Full Text] [Related]
53. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
54. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.
Kenyon EM; Del Razo LM; Hughes MF
Toxicol Sci; 2005 May; 85(1):468-75. PubMed ID: 15703264
[TBL] [Abstract][Full Text] [Related]
55. Gene expression of normal human epidermal keratinocytes modulated by trivalent arsenicals.
Bailey KA; Hester SD; Knapp GW; Owen RD; Thai SF
Mol Carcinog; 2010 Dec; 49(12):981-98. PubMed ID: 20886546
[TBL] [Abstract][Full Text] [Related]
56. Inorganic arsenic-induced intramitochondrial granules in mouse urothelium.
Suzuki S; Arnold LL; Muirhead D; Lu X; Le XC; Bjork JA; Wallace KB; Ohnishi T; Kakiuchi-Kiyota S; Pennington KL; Cohen SM
Toxicol Pathol; 2008 Dec; 36(7):999-1005. PubMed ID: 19126794
[TBL] [Abstract][Full Text] [Related]
57. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
Hayakawa T; Kobayashi Y; Cui X; Hirano S
Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
[TBL] [Abstract][Full Text] [Related]
58. Differential toxicity and gene expression in Caco-2 cells exposed to arsenic species.
Calatayud M; Devesa V; Vélez D
Toxicol Lett; 2013 Mar; 218(1):70-80. PubMed ID: 23353816
[TBL] [Abstract][Full Text] [Related]
59. Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing.
Moe B; Peng H; Lu X; Chen B; Chen LWL; Gabos S; Li XF; Le XC
J Environ Sci (China); 2016 Nov; 49():113-124. PubMed ID: 28007166
[TBL] [Abstract][Full Text] [Related]
60. Arsenite and its mono- and dimethylated trivalent metabolites enhance the formation of benzo[a]pyrene diol epoxide-DNA adducts in Xeroderma pigmentosum complementation group A cells.
Shen S; Lee J; Cullen WR; Le XC; Weinfeld M
Chem Res Toxicol; 2009 Feb; 22(2):382-90. PubMed ID: 19146383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
